Over 14 months of meticulous charting, Hims & Hers Health ($HIMS) has revealed its volatile nature, offering traders a unique opportunity to navigate its erratic swings. With the stock fluctuating...
Robinhood Markets, Inc. emerges as a compelling investment, blending undervaluation with robust market leadership in retail trading. With assets under custody reaching $255 billion and equity trading volumes at $180...
Nvidia's strategic acquisition of Canadian AI startup CentML highlights its commitment to dominating AI efficiency. By focusing on optimising AI workloads, Nvidia is poised to reduce inference costs—a critical concern...
As we delve into 2025, the twin forces of financial sector earnings and inflation data promise to shape the market's early trajectory. Heavyweights like JPMorgan and Goldman Sachs will reveal...
When pharmaceutical behemoths face regulatory pressures or lose a blockbuster drug's patent protection, it often unveils a contrarian investment opportunity. As giants scramble for solutions, M&A activity may soar, creating...
The passage of the GENIUS Act by the U.S. Senate marks a historic move towards a regulatory framework for stablecoins, promising to reshape digital asset integration into the financial system....
Oscar Health (OSCR) is enjoying an exhilarating 8% pre-market surge, riding high on the decision by Republican senators to exclude Medicare Advantage cuts from their tax bill. This legislative twist...
PepsiCo stock is flirting with a dramatic rebound, leaping from near $131 towards its 200-week moving average of $167. This potential 27% upside is sweetened by a robust 4.3% dividend...
